Sarcoma, Secondary cancers, Soft tissue sarcoma
Results
Phase 2
This trial looked at cabazitaxel for liposarcoma that had spread to other parts of the body. Or it wasn’t possible to remove the sarcoma with surgery. This is advanced liposarcoma.
The trial was open for people to join between 2017 and 2019. The team presented the results at a conference in 2020.
Recruitment start: 1 March 2015
Recruitment end: 31 March 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard L Hayward
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Sanofi
Last reviewed: 11 October 2022
CRUK internal database number: 12333